| mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
-0.0049 |
0.9 |
| mRNA |
BRD-K48334597 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.9 |
| mRNA |
XMD13-2 |
GDSC1000 |
pan-cancer |
AAC |
-0.0044 |
0.9 |
| mRNA |
UNC0321 |
CTRPv2 |
pan-cancer |
AAC |
0.0049 |
0.9 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0049 |
0.9 |
| mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
-0.0043 |
0.9 |
| mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.005 |
0.9 |
| mRNA |
PD-0332991 |
CCLE |
pan-cancer |
AAC |
0.0064 |
0.9 |
| mRNA |
Crizotinib |
CCLE |
pan-cancer |
AAC |
-0.0062 |
0.9 |
| mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0047 |
0.9 |